Learn more

SHIN NIPPON BIOMEDICAL LAB LTD

Overview
  • Total Patents
    79
  • GoodIP Patent Rank
    117,761
About

SHIN NIPPON BIOMEDICAL LAB LTD has a total of 79 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), Japan and China. Its main competitors in its focus markets pharmaceuticals, agriculture and telecommunications are SHIN NIPPON BIOMEDICAL LABORATORIES LTD, OPTERION HEALTH AG and VALEANT PHARMACEUTICALS NORTH AMERICA.

Patent filings per year

Chart showing SHIN NIPPON BIOMEDICAL LAB LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Nagata Ryoichi 48
#2 Haruta Shunji 22
#3 Tsutsui Tatsuo 9
#4 Magotani Hiroaki 8
#5 Kashima Masatoshi 8
#6 Gemba Takefumi 7
#7 Uno Yasuhiro 7
#8 Uto Masahiro 5
#9 Yamashita Hidetoshi 4
#10 Suzuki Nobuyuki 3

Latest patents

Publication Filing date Title
WO2015108048A1 Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
CA2923270A1 Intranasal formulation for the treatment of cardiopulmonary resuscitation (cpr), cardiac life support (cls), anaphylaxis and/or anaphylactoid reactions
WO2015022953A1 Blood-brain barrier disorder improvement agent
WO2015002150A1 Novel compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor
JP2014158478A Novel drug metabolizing enzyme in monkey
JP2014158479A Novel drug metabolizing enzyme in monkey
JP2015053935A Method for detecting polymorphism of monkey cyp2c and cyp2d gene and use thereof
SG185658A1 Primate restraint device
JP2013240316A Restrainer for primate
JP2013240301A Restrainer for primate
JP2013188147A Working platform
JP2015078129A Fibromyalgia therapeutic agent containing donepezil
KR20130083376A Methods and compositions for intranasal delivery
JP2012055274A New drug-metabolizing enzyme of monkey
EP2462800A1 Primate retaining device
CN102480928A Primate Restraining Device
GB201012959D0 Intranasal granisetron and nasal applicator
WO2010131486A1 Intranasal pharmaceutical compositions with improved pharmacokinetics
JP2010220546A Detection and use of ape cyp3a gene polymorphism
JP2008026737A Image display system